newsfilter
← Latest News
GlobeNewswire·

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Results in a population of 278 patients affirm statistically significant mortality reductionsBenefits observed across severity groups and in subjects with serious comorbiditiesCompany files provisional patent